About

Abdul Basit, PhD, is Professor of Pharmaceutics at UCL School of Pharmacy. Professor Basit’s research sits at the interface between pharmaceutical science and gastro-enterology, forging links between basic science and clinical outcomes. He is an international authority on oral drug delivery and absorption, and has published over 300 papers, book chapters, abstracts, and patents. He leads a large and multi-disciplinary research group, and the goal of his work is to further the understanding of GI physiology by fundamental research.

He is a frequent speaker at international conferences, serves as a consultant to numerous pharmaceutical companies and is on the advisory boards of healthcare organisations, charitable bodies and scientific journals.

Contributions

EARLY INSIGHT

PERSONALISING DRUG PRODUCTS USING 3D PRINTING

Sarah Trenfield and Abdul Basit look at the potential applications of 3D-printing technology to create personalised drug therapies in fields such as multiple drug therapy and paediatric/geriatric care and introduce FabRx’s 3D-printing system, which can produce formulations to suit a variety of situations.

More contributions

GI/ORAL

OPPORTUNITIES & INNOVATIONS IN COLONIC DRUG DELIVERY

Sejal R Ranmal, Vipul Yadav and Abdul W Basit describe recent insights into the physiology of the colon, advantages of targeting drug release to the colon and introduce Phloral®, Intract’s unique system for achieving drug release in the colon successfully and consistently.